The table below shows Roivant Sciences Ltd.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Revenue
$8.26M
$29.05M
$32.71M
$31.53M
$55.29M
$23.80M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$681.81M
$550.41M
$439.91M
$454.06M
$483.04M
$236.63M
SG&A
ROIV annual revenue (10-K history)
Roivant Sciences Ltd. reported annual revenue of $8.26M for fiscal year 2026. That is down 71.6% from $29.05M in fiscal 2025. Over the 6 fiscal years shown, annual revenue declined from $23.80M (FY 2021) to $8.26M. Figures come from the company's audited annual reports as filed with the SEC.
